261 related articles for article (PubMed ID: 30185893)
1. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas.
Creemers A; Ebbing EA; Pelgrim TC; Lagarde SM; van Etten-Jamaludin FS; van Berge Henegouwen MI; Hulshof MCCM; Krishnadath KK; Meijer SL; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Sci Rep; 2018 Sep; 8(1):13281. PubMed ID: 30185893
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.
McCormick Matthews LH; Noble F; Tod J; Jaynes E; Harris S; Primrose JN; Ottensmeier C; Thomas GJ; Underwood TJ
Br J Cancer; 2015 Jun; 113(1):107-18. PubMed ID: 26110972
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of epidermal growth factor receptor overexpression in patients with esophageal adenocarcinoma: a meta-analysis.
Guo YM; Yu WW; Zhu M; Guo CY
Dis Esophagus; 2015; 28(8):750-6. PubMed ID: 24961755
[TBL] [Abstract][Full Text] [Related]
6. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
7. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.
Ong CA; Shapiro J; Nason KS; Davison JM; Liu X; Ross-Innes C; O'Donovan M; Dinjens WN; Biermann K; Shannon N; Worster S; Schulz LK; Luketich JD; Wijnhoven BP; Hardwick RH; Fitzgerald RC
J Clin Oncol; 2013 Apr; 31(12):1576-82. PubMed ID: 23509313
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.
Yagi T; Baba Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Ann Surg; 2019 Mar; 269(3):471-478. PubMed ID: 29206673
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis.
Chen M; Cai E; Huang J; Yu P; Li K
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1126-34. PubMed ID: 22564870
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival.
Loeser H; Scholz M; Fuchs H; Essakly A; Damanakis AI; Zander T; Büttner R; Schröder W; Bruns C; Quaas A; Gebauer F
Sci Rep; 2020 Oct; 10(1):18411. PubMed ID: 33110104
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
Borg D; Larsson AH; Hedner C; Nodin B; Johnsson A; Jirström K
J Transl Med; 2018 Oct; 16(1):290. PubMed ID: 30355278
[TBL] [Abstract][Full Text] [Related]
14. Profiles of autophagy-related genes in esophageal adenocarcinoma.
Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
[TBL] [Abstract][Full Text] [Related]
15. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis.
Lorton CM; Higgins L; O'Donoghue N; Donohoe C; O'Connell J; Mockler D; Reynolds JV; Walsh D; Lysaght J
Ann Surg Oncol; 2022 Mar; 29(3):1853-1865. PubMed ID: 34773194
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
17. MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.
Davison JM; Ellis ST; Foxwell TJ; Luketich JD; Gibson MK; Kuan SF; Nason KS
Hum Pathol; 2014 Mar; 45(3):540-8. PubMed ID: 24290360
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer: A meta-analysis of the literature.
Yu W; Guo Y
Medicine (Baltimore); 2018 Jul; 97(30):e11614. PubMed ID: 30045299
[TBL] [Abstract][Full Text] [Related]
20. The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
Humphries MP; Craig SG; Kacprzyk R; Fisher NC; Bingham V; McQuaid S; Murray GI; McManus D; Turkington RC; James J; Salto-Tellez M
BMC Cancer; 2020 Jun; 20(1):500. PubMed ID: 32487090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
